Syngen BiotechLtd Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 8279?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,156,2354.27%
Private Companies1,703,9986.29%
Individual Insiders1,893,7196.99%
General Public9,695,75335.8%
Public Companies12,651,14646.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 8 shareholders own 64.22% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
46.7%
Standard Chemical & Pharmaceutical Co. Ltd.
12,651,146NT$2.0b0%no data
5.84%
Wei-Ren Chen
1,581,634NT$251.5m0%no data
4.07%
FMR LLC
1,104,237NT$175.6m-1.9%no data
3.7%
Dahausen Co., Ltd.
1,002,929NT$159.5m0%no data
2.59%
Yingsheng Investment Co., Ltd.
701,069NT$111.5m62.5%no data
1.15%
Cui Ye
312,085NT$49.6m0%no data
0.11%
First Securities Investment Trust Co., Ltd.
28,929NT$4.6m0%0.01%
0.085%
Dimensional Fund Advisors LP
23,069NT$3.7m-0.22%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.